UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:July 14,
Trevi Therapeutics (NASDAQ:TRVI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Trevi Therapeutics Charts.
Trevi Therapeutics (NASDAQ:TRVI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Trevi Therapeutics Charts.

Trevi Therapeutics, Inc. News

Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024
Thursday 2 May 2024 (3 days ago) • PR Newswire (US)
FNB Harvest annonce les distributions d’avril 2024
Tuesday 23 April 2024 (2 weeks ago) • Business Wire
Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference
Tuesday 9 April 2024 (4 weeks ago) • PR Newswire (US)
Trevi Therapeutics to Participate in Upcoming April Events
Thursday 4 April 2024 (1 month ago) • PR Newswire (US)
Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
Tuesday 2 April 2024 (1 month ago) • PR Newswire (US)
FNB Harvest annonce les distributions de mars 2024
Thursday 21 March 2024 (1 month ago) • Business Wire
Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
Thursday 21 March 2024 (1 month ago) • PR Newswire (US)
Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024
Thursday 14 March 2024 (2 months ago) • PR Newswire (US)
Trevi Therapeutics to Participate in Upcoming March Events
Wednesday 28 February 2024 (2 months ago) • PR Newswire (US)
FNB Harvest annonce les distributions de février 2024
Thursday 22 February 2024 (2 months ago) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)

More Trevi Therapeutics, Inc. News Articles